UBS Upgrades Smith & Nephew (SNN) to Buy
More News related to SNN
- Smith & Nephew Advanced Wound Management Appoints Thomas Dugan to Lead North American Business
- Smith & Nephew Plc - Transaction in Own Shares
- Global Medical Devices Company Selects Varicent Performance Management Software
- Smith & Nephew Plc - Transaction in Own Shares
- Transaction in Own Shares
More News related to Upgrades
- Feltl Upgrades On Track Innovations (OTIV) to Strong Buy
- Amylin (AMLN) Gets A Friend After Yesterday's 25% Sell-Off
- Pacific Crest Upgrades SunPower (SPWR) to Outperform
- Maxim Group Upgrades Excel Maritime (EXM), Eagle Bulk (EGLE), Genco (GNK) to Buy
- Matrix USA Rating Changes 8/28
UBS upgrades Smith & Nephew (NYSE: SNN) from Neutral to Buy.
Smith & Nephew plc is a global medical devices company engaged in the development, manufacture and marketing of medical devices in the sectors of orthopedic reconstruction, orthopedic trauma and clinical therapies, endoscopy and advanced wound management.
Related Categories
UpgradesStocks Mentioned
+0.51Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
